Approval · Notice of Compliance 24238 · 2020
NOZINAN: Notice of Compliance 24238
Issued September 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24238
- Date
- September 17, 2020
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the labels and package insert to better align with the current plain language labelling regulations
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOZINAN | Not yet assigned | — |
Medicinal ingredients
- METHOTRIMEPRAZINE HCL 25 MG per ML